Open Access
Open access
volume 9 issue 6 pages 35

Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells

Mohammad Hossain 1
Praveen K. Roayapalley 2
Hiroshi Sakagami 3
Keitaro Satoh 3
Kenjiro Bandow 3
Umashankar Das 2
Jonathan R Dimmock 2
Publication typeJournal Article
Publication date2022-06-08
SJR
CiteScore
Impact factor
ISSN23056320
General Medicine
Abstract

A series of 3,5-bis(benzylidene)-1-dichloroacetyl-4-piperidones 1a–l was evaluated against Ca9-22, HSC-2, HSC-3, and HSC-4 squamous cell carcinomas. Virtually all of the compounds displayed potent cytotoxicity, with 83% of the CC50 values being submicromolar and several CC50 values being in the double digit nanomolar range. The compounds were appreciably less toxic to human HGF, HPLF, and HPC non-malignant cells, which led to some noteworthy selectivity index (SI) figures. From these studies, 1d,g,k emerged as the lead molecules in terms of their potencies and SI values. A Quantitative Structure-Activity Relationship (QSAR) study revealed that cytotoxic potencies and potency–selectivity expression figures increased when the magnitude of the sigma values in the aryl rings was elevated. The modes of action of the representative cytotoxins in Ca9-22 cells were found to include G2/M arrest and stimulation of the cells to undergo mitosis and cause poly(ADP-ribose) polymerase (PARP) and procaspase 3 cleavage.

Found 
Found 

Top-30

Journals

1
Russian Chemical Reviews
1 publication, 100%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Share
Cite this
GOST |
Cite this
GOST Copy
Hossain M. et al. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells // Medicines. 2022. Vol. 9. No. 6. p. 35.
GOST all authors (up to 50) Copy
Hossain M., Roayapalley P. K., Sakagami H., Satoh K., Bandow K., Das U., Dimmock J. R. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells // Medicines. 2022. Vol. 9. No. 6. p. 35.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/medicines9060035
UR - https://doi.org/10.3390/medicines9060035
TI - Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells
T2 - Medicines
AU - Hossain, Mohammad
AU - Roayapalley, Praveen K.
AU - Sakagami, Hiroshi
AU - Satoh, Keitaro
AU - Bandow, Kenjiro
AU - Das, Umashankar
AU - Dimmock, Jonathan R
PY - 2022
DA - 2022/06/08
PB - MDPI
SP - 35
IS - 6
VL - 9
PMID - 35736248
SN - 2305-6320
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Hossain,
author = {Mohammad Hossain and Praveen K. Roayapalley and Hiroshi Sakagami and Keitaro Satoh and Kenjiro Bandow and Umashankar Das and Jonathan R Dimmock},
title = {Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells},
journal = {Medicines},
year = {2022},
volume = {9},
publisher = {MDPI},
month = {jun},
url = {https://doi.org/10.3390/medicines9060035},
number = {6},
pages = {35},
doi = {10.3390/medicines9060035}
}
MLA
Cite this
MLA Copy
Hossain, Mohammad, et al. “Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells.” Medicines, vol. 9, no. 6, Jun. 2022, p. 35. https://doi.org/10.3390/medicines9060035.